Growth through collaborations Strategic partnerships with international dairy and nutrition players (e.g., Sunplus in China) indicate a pathway to co-develop bovine colostrum products and expand global distribution. Sales reps should target co-branding, joint clinical research, and license/contract manufacturing opportunities with mid- to large-scale food and biotech manufacturers.

Clinical leadership The addition of a Scientific Advisory Board and emphasis on gut and immune health signals opportunities to sell to hospitals, clinics, and practitioner networks. Consider proposing physician-led education programs, clinician-backed product lines, and practitioner-exclusive formulations to drive credibility and adoption.

Niche GLP-1 support Relesium addresses gut-related side effects of GLP-1 medications, aligning with the growing market for obesity and diabetes pharmacotherapy support products. Target weight-management clinics, endocrinologists, and pharmaceutical care programs to position as a complementary supplement for patients using GLP-1 therapies.

Early life opportunity Focus on pediatric and family health segments given prior TruBiotics extensions and emphasis on early life nutrition. Develop partnerships with pediatric practices, daycare programs, and consumer product channels targeting families with kids seeking digestive and immune support.

Private label potential Multiple product launches across probiotic gummies, bovine colostrum supplements, and practitioner-exclusive lines show readiness for private-label or contract-manufacturing deals. Propose turnkey white-label solutions for retailers, clinics, and global distributors seeking speed-to-market with science-backed formulations.